Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
Tong L, Pan C, Wang H, Bertolini M, Lew E, Meneghini LF. Tong L, et al. Among authors: bertolini m. Diabetes Obes Metab. 2018 Apr;20(4):831-839. doi: 10.1111/dom.13156. Epub 2017 Dec 4. Diabetes Obes Metab. 2018. PMID: 29119712 Free PMC article.
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.
Ritzel R, Harris SB, Baron H, Florez H, Roussel R, Espinasse M, Muehlen-Bartmer I, Zhang N, Bertolini M, Brulle-Wohlhueter C, Munshi M, Bolli GB. Ritzel R, et al. Among authors: bertolini m. Diabetes Care. 2018 Aug;41(8):1672-1680. doi: 10.2337/dc18-0168. Epub 2018 Jun 12. Diabetes Care. 2018. PMID: 29895556 Clinical Trial.
Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes Care 2018;41:1672-1680.
Ritzel R, Harris SB, Baron H, Florez H, Roussel R, Espinasse M, Muehlen-Bartmer I, Zhang N, Bertolini M, Brulle-Wohlhueter C, Munshi M, Bolli GB. Ritzel R, et al. Among authors: bertolini m. Diabetes Care. 2019 Aug;42(8):1604. doi: 10.2337/dc19-er08. Epub 2019 Jun 21. Diabetes Care. 2019. PMID: 31227584 Free PMC article. No abstract available.
Metabolic effects of fluoxetine in obese menopausal women.
Bondi M, Menozzi R, Bertolini M, Venneri MG, Del Rio G. Bondi M, et al. Among authors: bertolini m. J Endocrinol Invest. 2000 May;23(5):280-6. doi: 10.1007/BF03343724. J Endocrinol Invest. 2000. PMID: 10882145 Clinical Trial.
384 results